指南与共识皮肤感染

欧洲带状疱疹管理共识指南(S2k)第一部分:诊断

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2016-11-02

该指南由欧洲皮肤病论坛与欧洲皮肤病与性病学会合作制定,采用AGREE II质量标准的结构化流程,由皮肤科、病毒学/感染科、眼科、耳鼻喉科、神经科和麻醉科专家组成专家组。第一部分评估了带状疱疹的诊断手段,并经正式共识会议形成针对疑似或确诊带状疱疹患者评估与管理的推荐,供临床应用时结合本国法规与报销情况参考。

要点

  • 指南为S2k共识,覆盖带状疱疹诊断评估及不同临床情境。
  • 专家组多学科组成,推荐经正式共识会议通过。
  • 应用时需结合各国法规、可及性与报销情况。

核心结论

  • 该欧洲S2k共识指南第一部分针对(疑似)带状疱疹患者的诊断与管理评估形成正式共识推荐。

研究设计与样本

  • 指南制定遵循结构化预设流程并参考AGREE II质量标准,由指导组负责规划组织。
  • 专家组由皮肤科、病毒学/感染科、眼科、耳鼻喉科、神经科和麻醉科专家按临床或科研经验提名。
  • 推荐经共识会议正式同意,并经内部与外部审查后由委托学会批准。

主要发现

  • 第一部分评估了带状疱疹的诊断手段。
  • 专家组针对(疑似)带状疱疹患者的管理形成正式共识推荐,涵盖多种具体临床情境下的评估。

临床怎么用

  • 临床使用者应仔细核查推荐是否适用于其预期应用场景。
  • 在国际指南背景下,需考虑各国在诊断和治疗干预的监管批准、可及性与报销方面的不同做法与法律环境。

局限性

  • 作为国际指南,应用时需考虑各国法规、可及性与报销差异,推荐需结合具体情境核查适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration of a consensus-based guideline on the management of patients who present with HZ, considering different patient populations and different localizations. This interdisciplinary guideline aims at an improvement of the outcomes of the acute HZ management concerning disease duration, acute pain and quality of life of the affected patients and at a reduction of the incidence of postherpetic neuralgia and other complications. The guideline development followed a structured and predefined process, considering the quality criteria for guidelines development as suggested by the AGREE II instrument. The steering group was responsible for the planning and the organization of the guideline development process (Division of Evidence based Medicine, dEBM). The expert panel was nominated by virtue of clinical expertise and/or scientific experience and included experts from the fields of dermatology, virology/infectiology, ophthalmology, otolaryngology, neurology and anaesthesiology. Recommendations for clinical practice were formally consented during the consensus conference, explicitly considering different relevant aspects. The guideline was approved by the commissioning societies after an extensive internal and external review process. In this first part of the guideline, diagnostic means have been evaluated. The expert panel formally consented recommendations for the management of patients with (suspected) HZ, referring to the assessment of HZ patients, considering various specific clinical situations. Users of the guideline must carefully check whether the recommendations are appropriate for the context of intended application. In the setting of an international guideline, it is generally important to consider different national approaches and legal circumstances with regard to the regulatory approval, availability and reimbursement of diagnostic and therapeutic interventions.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Werner RN, Nikkels AF, Marinović B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J Eur Acad Dermatol Venereol. 2016. PMID: 27804172. doi:10.1111/jdv.13995

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。